Common use of LICENSE TO COMPOUNDS Clause in Contracts

LICENSE TO COMPOUNDS. NeoGenesis hereby grants to Schering, and Schering hereby accepts, an exclusive (even as to NeoGenesis), right and license in the Territory and within the Field under the NeoGenesis Patent Rights and to use the NeoGenesis Know-How to research, develop, make, have made, import, export and use the Selected Compounds (and Active Compounds, Improved Active Compounds and Preliminary Compounds of the same Chemotype as such Selected Compounds), Designated Compounds and Derivative Compounds, for research purposes and to develop Licensed Products. The licenses granted to Schering under this Section 3.2 include the right to grant sublicenses to Affiliates or third parties in accordance with the provisions of Section 3.3. Schering shall xxxx or have marked all containers or packages of Selected Compounds Derivative Compounds and Designated Compounds that are the subject of the license granted under this Section 3.1 in accordance with the patent marking laws of the jurisdiction in which such Selected Compounds, Derivative Compounds and Designated Compounds are manufactured, used or sold.

LICENSE TO COMPOUNDS. NeoGenesis hereby grants to ScheringSPL, and Schering SPL hereby accepts, an exclusive (even as to NeoGenesis), right and license in the Territory and within the Field under the NeoGenesis Patent Rights and to use the NeoGenesis Know-How to research, develop, make, have made, import, export and use the Selected Compounds (and Active Compounds, Improved Active Compounds and Preliminary Compounds of the same Chemotype as such Selected Compounds), Designated Compounds and Derivative Compounds, for research purposes and to develop Licensed Products. The licenses granted to Schering SPL under this Section 3.2 include the right to grant sublicenses to Affiliates or third parties in accordance with the provisions of Section 3.3. Schering SPL shall xxxx or have marked all containers or packages of Selected Compounds Derivative Compounds and Designated Compounds that are the subject of the license granted under this Section 3.1 in accordance with the patent marking laws of the jurisdiction in which such Selected Compounds, Derivative Compounds and Designated Compounds are manufactured, used or sold.